Literature DB >> 7197513

Paradoxical cortisol responses to dextroamphetamine in endogenous depression.

E J Sachar, U Halbreich, G M Asnis, R S Nathan, F S Halpern, L Ostrow.   

Abstract

Dextroamphetamine hydrochloride was administered intravenously (IV) in the morning and evening to 22 unmedicated patients with severe endogenous depressions and 18 normal control subjects. While the normal subjects generally had a sharp increase in plasma cortisol level by 30 minutes after drug administration, two thirds of the depressed patients showed instead a paradoxical suppression of cortisol levels by 60 minutes. Discrimination between normal subjects and depressives was greatest in the evening. These results are consistent with other reports of abnormal cortisol responses in depressed patients to smaller IV doses of dextroamphetamine and larger doses of methamphetamine hydrochloride. A defect in activation or noradrenergic alpha receptors may account, in part, for the abnormal cortisol responses. The dextroamphetamine cortisol test in other patient populations requires study before its diagnostic use in endogenous depression can be established.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7197513     DOI: 10.1001/archpsyc.1981.01780350047005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  3 in total

Review 1.  Drugs and HPA axis.

Authors:  Alberto Giacinto Ambrogio; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  Short circuit: Disaggregation of adrenocorticotropic hormone and cortisol levels in HIV-positive, methamphetamine-using men who have sex with men.

Authors:  Adam W Carrico; Violeta J Rodriguez; Deborah L Jones; Mahendra Kumar
Journal:  Hum Psychopharmacol       Date:  2017-12-21       Impact factor: 1.672

3.  d-Amphetamine raises cortisol levels in schizophrenic patients with and without chronic naltrexone pretreatment.

Authors:  D P van Kammen; S C Schulz
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.